Teranode Fuels Life Sciences R&D Projects with New Reagent Production Offering, Unveils Solutions Roadmap to Extend Platform for Closed-Loop R&D
Teranode Corporation, the leading innovator of design automation software for the Life Sciences industry, today announced the general availability of TERANODE Reagent Production, a flexible laboratory solution that supports reagent production control, QA, and reporting. The new solution improves production productivity in support of divergent R&D projects in life sciences. Teranode also announced today that the TERANODE Reagent Production is the first of several solutions the company will release over the coming year to link laboratories together to create closed-loop R&D. Other solutions to be released in 2005 include: TERANODE Pathway Analytics, TERANODE Sample Processing, and TERANODE HTS.
“Closed loop R&D represents an important shift in laboratory informatics. Life Science Insights predicts that laboratory managers will increasingly adopt this technology once they’ve used the Teranode platform,” said James Golden, Vice President of Research for Life Science Insights, an IDC Company.
Productivity within each Life Sciences R&D phase is challenged by increasingly complex physical and process science, combined with exploding collections of data. Closed-loop R&D helps laboratories design, manage, analyze, and report experiments to accelerate collaboration, decision-making, and compliance across Life Sciences R&D, and is critical in each phase of the discovery and development process.
TERANODE Reagent Production Fuels R&D Projects
Today’s reagent production informatics landscape is wrought with manual processes that gather data in spreadsheets or desktop databases and are inefficient, as well as error-prone. This manual informatics landscape presents a constant challenge to R&D professionals to find more streamlined, accurate solutions to accelerate experiments. The alternative is traditional Laboratory Information Management Systems (LIMS), which are often too rigid to be cost-effectively adapted to research projects’ dynamic production requirements. TERANODE Reagent Production solution eliminates the need to rely on manual informatics or inflexible solutions and ensures accurate and on-time production of reagents.
Dr. Paul H. Johnson, senior vice president, Research & Development, and Chief Scientific Officer for Nastech Pharmaceutical Company Inc., has realized significant gains and notes, “The TERANODE Reagent Production was chosen to link our peptide production and phage display groups together to accelerate our research. Using a common repository gives us the potential to improve the quality of our experimental data, as well as the responsiveness of our research organization.”
Laboratory professionals can now take advantage of a customer proven solution that is flexible to changing production requirements. TERANODE Reagent Production is deployed without any programming, enabling users to experience a quick return on investment. Key features of the TERANODE Reagent Production solution include:
- Library of Protocols
With the TERANODE Reagent Production technology, laboratories have access to customer-proven protocols for chemical synthesis, peptide synthesis, and other procedures. - Library of Integrations to Laboratory Equipment
TERANODE Reagent Production includes integrations to laboratory instruments such as Waters® through FractionalLynx™ and MassLynx™. - Installation and Configuration Services
Because TERANODE Reagent Production is easily deployed without any additional programming, organizations instantly see return value in their investment.
“Reagent production is critical to life sciences R&D and must be both responsive and reliable to accelerate drug development and other projects,” said Neil Fanger, COO and Teranode Industry Development Leader. “The availability of TERANODE Reagent Production allows us to offer a solution to R&D organizations whose operations are too dynamic for rigid LIMS. Over the coming year, we will be delivering other compelling solutions that further link laboratories together, tightening and making R&D more productive.”
A whitepaper titled, “Optimizing Reagent Production in Life Sciences R&D” is available at http://www.teranode.com/docs/reagent_production.pdf .
Pricing and Availability
Pricing for TERANODE Reagent Production, including installation and education, begins at $50,000 and is available immediately for purchase. For additional pricing information please email sales@teranode.com .
About Teranode Design Suite
Design automation software is purpose-built to close the informatics loop in R&D while leveraging the advances in laboratory automation and analytic tools. Closing the informatics loop in R&D requires: a holistic approach of model and data integration; a common repository which supports scientific collaboration, and cost-effective deployment to the individual user or enterprise process. TERANODE Design Suite provides the comprehensive set of capabilities that makes closed-loop informatics possible for Life Sciences R&D. TERANODE Design Suite can break the paradox of R&D productivity to deliver real leverage from advances in physical and process science.
About Teranode Corporation
Teranode Corporation, headquartered in Seattle, WA, is the leading innovator of design automation software to accelerate decision-making, collaboration, and compliance in the Life Sciences industry. The company, founded in 2002 to revolutionize the role that computing plays in Life Sciences, began with technologies invented by the founders at the University of Washington. TERANODE Design Suite is being used by leading pharmaceutical, biotechnology, research and academic organizations including Pfizer, AstraZeneca, St. Jude Children’s Research Hospital, and Fred Hutchinson Cancer Research Center.
For more information on Teranode please visit www.teranode.com .
